S. Chen

发表

GEM 231, a second-generation antisense agent complementary to protein kinase A RIalpha subunit, potentiates antitumor activity of irinotecan in human colon, pancreas, prostate and lung cancer xenografts.

Dong Yu, S. Agrawal, B. Hollister, 2002, International journal of oncology.

Role of Nucleoside Transport in Drug Action The Adenosine Deaminase Inhibitor, Deoxycoformycin, and the Antiplatelet Drugs, Dipyridamole and Dilazep a

R. Parks, J. Stoeckler, K. Agarwal, 1985, Annals of the New York Academy of Sciences.

Chemotherapy of mammary carcinomas arising in ras transgenic mice

D. Dexter, S. Chen, M. Diamond, 1993, Investigational New Drugs.

Distribution of the novel anticancer drug candidate brequinar sodium (DuP 785, NSC 368390) into normal and tumor tissues of nude mice bearing human colon carcinoma xenografts

D. Dexter, D. Behrens, Huey-shin L. Shen, 1988, Cancer Chemotherapy and Pharmacology.

S‐DEMETHYLATION OF NITROGEN HETEROCYCLES

R. P. Panzica, S. Chen, 1981 .

Synthesis and biological evaluation of certain 4‐alkylamino and 4‐arylalkylamino derivatives of the imidazo[4,5‐d]pyridazine and v‐triazolo[4,5‐d]pyridazine ring systems

D. Dexter, P. Calabresi, R. P. Panzica, 1982 .

PRECLINICAL STUDIES WITH BREQUINAR SODIUM: A NOVEL ANTICANCER AGENT

D. Dexter, S. Chen, 1992 .

Comparison of In Vitro Activities of Camptothecin and Nitidine Derivatives against Fungal and Cancer Cells

J. Heitman, M. Del Poeta, J. Perfect, 1999, Antimicrobial Agents and Chemotherapy.

Pyrrolo[2,3-d]Pyrimidine Nucleosides: Synthesis and Antitumor Activity of 7-Substituted 7-Deaza-2′-Deoxyadenosines

F. Seela, S. Chen, M. Zulauf, 2000, Nucleosides, nucleotides & nucleic acids.

Pyrrolo[2,3‐d]pyrimidine Nucleosides: Synthesis and Antitumor Activity of 7‐Substituted 7‐Deaza‐2′‐deoxyadenosines.

F. Seela, S. Chen, M. Zulauf, 2000 .

Biosynthesis Pyrimidine Nucleotide de Novo ( NSC 368390 ) : Inhibition of-biphenyl-4-yl )-3-methyl-4-quinolinecarboxylic Acid Sodium Salt ′-fluoro-1 , 1 ′ 6-Fluoro-2-( 2 Mechanism of Action of the Novel Anticancer Agent

D. Dexter, R. L. Ruben, S. Chen, 2006 .

ADENOSINE DEAMINASE INHIBITORS. CONVERSION OF A SINGLE CHIRAL SYNTHON INTO ERYTHRO- AND THREO-9-(2-HYDROXY-3-NONYL)ADENINES

M. Bessodes, G. Bastian, R. Parks, 1982 .

Deoxyinosine repair in nuclear extracts of human cells

Wern-Cherng Cheng, S. Goodman, W. Fang, 2015, Cell & Bioscience.

Preclinical activity of an i.v. formulation of rubitecan in IDD-P™ against human solid tumor xenografts

B. Hollister, H. Sands, J. Stoeckler, 2002, Anti-cancer drugs.

, against Fungal and Cancer Cells Camptothecin and Nitidine Derivatives Comparison of In Vitro Activities of

J. Heitman, M. Del Poeta, J. Perfect, 1999 .

Studies on the imidazo[4,5-d]pyridazine ring system. Course of alkylation of imidazo[4,5-d]pyridazine-4-thione

R. P. Panzica, S. Chen, 1981 .

Preclinical and phase I trials of topoisomerase I inhibitors

H. Burris, D. V. Hoff, M. Rothenberg, 2004, Cancer Chemotherapy and Pharmacology.

Screening and Validation of a Carvacrol-Targeting Viability-Regulating Protein, SLC6A3, in Liver Hepatocellular Carcinoma

Suqing Zhang, X. Yin, S. Chen, 2022, Disease markers.

Inhibition of dihydroorotate dehydrogenase activity by brequinar sodium.

D. Behrens, F. Perrella, S. Chen, 1992, Cancer research.

Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.

J. Miller, D. Dexter, C. Behrens, 1994, Cancer research.

Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF, MGI 114).

D. Troyer, C. Napier, J. Woynarowski, 1997, Biochemical pharmacology.